This guideline covers managing neuropathic pain (nerve pain) with pharmacological treatments (drugs) in adults in non-specialist settings. It aims to improve quality of life for people with conditions such as neuralgia, shingles and diabetic neuropathy by reducing pain and promoting increased participation in all aspects of daily living. The guideline sets out how drug treatments for neuropathic pain differ from traditional pain management.
off‑label [ 1 ] . The NICE guideline on depression in adults recommends that dosulepin should not be prescribed for adults with...
This guideline covers the longer-term psychological treatment and management of self-harm in people aged 8 and over. It aims to improve the quality of care and support for people who self harm and covers both single and recurrent episodes of self-harm.
CCGs , co-proxamol (paracetamol and dextropropoxyphene combination) and dosulepin are particularly relevant to risk from self-poisoning....
This guideline covers identifying and managing depression in adults aged 18 years and older, in primary and secondary care. It aims to improve care for people with depression by promoting improved recognition and treatment.
This guideline covers identifying, treating and managing depression in people aged 18 and over who also have a chronic physical health problem such as cancer, heart disease or diabetes. It aims to improve the care of people with a long-term physical health problem, which can cause or exacerbate depression. This has the potential to increase their quality of life and life expectancy.
The Academy of Medical Royal Colleges recently described our 'do not do' database as an excellent resource. The database allows you to search for recommendations that we've made on a clinical practice that should either be discontinued or not used routinely within the NHS. Take a look at the top 5 recommendations: